|
Presentation |
Media |
Date |
Alzecure: Intervju med vd Martin Jönsson (video)
|
|
|
March 1, 2021
|
Interview with Martin Jönsson CEO in Aktiespararna’s analysis guide
|
|
|
February 8, 2021
|
Improving Quality of Life for People with Neurodegenerative Diseases – Stockholm Researchers and Health Tech Companies
|
|
|
January 14, 2021
|
CEO Martin Jönsson presentation, Aktiedagen Lund
|
|
|
January 27, 2021
|
Interview with Johan Sandin (CSO) in Aktiespararna’s analysis guide
|
|
|
January 22, 2021
|
Alzecure: CEO Martin Jönsson presents at Redeye Life Science Day 2020
|
|
|
December 1, 2020
|
Scientific presentation on the NeuroRestore® candidate ACD856 presented at the CTAD conference
|
|
|
November 4-7, 2020
|
Scientific presentation on Alzstatin presented at the CTAD conference
|
|
|
November 4-7, 2020
|
Scientific and market update with professor Henrik Zetterberg on Alzheimer’s disease, bio-markers, potential future treatments, including Alzstatin and AlzeCure
|
|
|
September 30, 2020
|
AlzeCure presentation with CEO Martin Jönsson at Aktiespararna (Swedish)
|
|
|
September 8, 2020
|
AlzeCure Science & Market update about Alzheimer’s diseas and NeuroRestore (Swedish)
|
|
|
September 1, 2020
|
Welcome to AlzeCure … Introduction film about the company (Swedish) – 1 minute
|
|
|
|
CEO presentation at the annual meeting (Swedish)
|
|
|
May 20, 2021
|
Scientific presentation about ACD856, a positive modulator of neurotrophin signaling reverses scopolamine- or age-induced cognitive deficits
|
|
|
April 2-5, 2020
|
Get to know AlzeCure’s CEO Martin Jönsson – Redeye interview (Swedish)
|
|
|
March 19, 2020
|
AlzeCure presentation with CEO Martin Jönsson at Aktiespararna (Swedish)
|
|
|
March 16, 2020
|
About the Alzstatin® project Disease modifying treatment of Alzheimer’s disease
|
|
|
|
About Alzheimers disease
|
|
|
February 27, 2018
|
About the project NeuroRestore®, symptomatic treatment of cognitive disorders such as in Alzheimer’s disease
|
|
|
February 27, 2018
|